Baijin Life Science Holdings Limited
HKSE: 1466.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Consumer Cyclical
- Industry
- Luxury Goods
- CEO
- Sze Ming Cheung
- Employees
- 84
- Headquarters
- Central, Hong Kong SAR China
- IPO year
- 2014
- Market cap
- HK$425.4M
- Website
- https://www.baijinlifescience.com
Loading 1466…
Loading profile data…Frequently asked questions about 1466
What does Baijin Life Science Holdings Limited (1466.HK) do?
Affluent Partners Holdings Limited, an investment holding company, engages in the purchase, process, design, production, assembly, trade, and wholesale distribution of pearls and jewelry products. It operates in two segments, Sales of Pearls and Jewellery Products, and Strategic Investment and Financial Services. The company is also involved in...
Where does 1466.HK trade?
Baijin Life Science Holdings Limited (1466.HK) trades on the Hong Kong Stock Exchange.
What sector is 1466.HK in?
Baijin Life Science Holdings Limited (1466.HK) operates in the Consumer Cyclical sector, specifically in the Luxury Goods industry.
Who is the CEO of Baijin Life Science Holdings Limited?
Sze Ming Cheung is the chief executive officer of Baijin Life Science Holdings Limited (1466.HK).
Where is Baijin Life Science Holdings Limited headquartered?
Baijin Life Science Holdings Limited is headquartered in Hong Kong SAR China.
Does 1466.HK pay a dividend?
Baijin Life Science Holdings Limited (1466.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 1466.HK go public?
Baijin Life Science Holdings Limited (1466.HK) completed its initial public offering in 2014.